145 related articles for article (PubMed ID: 38683861)
1. Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.
Kariya Y; Hamatake M; Urano E; Yoshiyama H; Shimizu N; Komano J
Cancer Sci; 2010 Apr; 101(4):876-81. PubMed ID: 20132216
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma.
Fukayama M; Hino R; Uozaki H
Cancer Sci; 2008 Sep; 99(9):1726-33. PubMed ID: 18616681
[TBL] [Abstract][Full Text] [Related]
3. A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency.
Ward BJH; Prasai K; Schaal DL; Wang J; Scott RS
PLoS Pathog; 2023 Dec; 19(12):e1011873. PubMed ID: 38113273
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis patient-derived spontaneous B cells have distinct EBV and host gene expression profiles in active disease.
Soldan SS; Su C; Monaco MC; Yoon L; Kannan T; Zankharia U; Patel RJ; Dheekollu J; Vladimirova O; Dowling JW; Thebault S; Brown N; Clauze A; Andrada F; Feder A; Planet PJ; Kossenkov A; Schäffer DE; Ohayon J; Auslander N; Jacobson S; Lieberman PM
Nat Microbiol; 2024 Jun; 9(6):1540-1554. PubMed ID: 38806670
[TBL] [Abstract][Full Text] [Related]
5. EBV Persistence--Introducing the Virus.
Thorley-Lawson DA
Curr Top Microbiol Immunol; 2015; 390(Pt 1):151-209. PubMed ID: 26424647
[TBL] [Abstract][Full Text] [Related]
6. Is Epstein Barr virus latency protective against type 1 diabetes?
Zoledziewska M
Med Hypotheses; 2024 Apr; 185():. PubMed ID: 38800669
[No Abstract] [Full Text] [Related]
7. Targeting latent viral infection in EBV-associated lymphomas.
Kong IY; Giulino-Roth L
Front Immunol; 2024; 15():1342455. PubMed ID: 38464537
[TBL] [Abstract][Full Text] [Related]
8. Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression.
Liao Y; Yan J; Beri NR; Giulino-Roth L; Cesarman E; Gewurz BE
PLoS Pathog; 2024 Apr; 20(4):e1011939. PubMed ID: 38683861
[TBL] [Abstract][Full Text] [Related]
9. Germinal Center Cytokines Driven Epigenetic Control of Epstein-Barr Virus Latency Gene Expression.
Yifei L; Jinjie Y; Beri NR; Roth LG; Ethel C; Benjamin E G
bioRxiv; 2024 Jan; ():. PubMed ID: 38260430
[TBL] [Abstract][Full Text] [Related]
10. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
[TBL] [Abstract][Full Text] [Related]
11. The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas.
Takacs M; Segesdi J; Banati F; Koroknai A; Wolf H; Niller HH; Minarovits J
Mediterr J Hematol Infect Dis; 2009 Nov; 1(2):e2009012. PubMed ID: 21416002
[TBL] [Abstract][Full Text] [Related]
12. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
[TBL] [Abstract][Full Text] [Related]
13. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-27 in Epstein-Barr virus infection revealed by IL-27RA deficiency.
Martin E; Winter S; Garcin C; Tanita K; Hoshino A; Lenoir C; Fournier B; Migaud M; Boutboul D; Simonin M; Fernandes A; Bastard P; Le Voyer T; Roupie AL; Ben Ahmed Y; Leruez-Ville M; Burgard M; Rao G; Ma CS; Masson C; Soudais C; Picard C; Bustamante J; Tangye SG; Cheikh N; Seppänen M; Puel A; Daly M; Casanova JL; Neven B; Fischer A; Latour S
Nature; 2024 Apr; 628(8008):620-629. PubMed ID: 38509369
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
